Export 131 results:
Filters: Author is J-P Julien  [Clear All Filters]
G. Gowing, Philips, T., Van Wijmeersch, B., Audet, J. - N., Dewil, M., Van Den Bosch, L., Billiau, A. D., Robberecht, W., and J-P Julien, Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase., J Neurosci, vol. 28, no. 41, pp. 10234-44, 2008.
F. Gros-Louis, Kriz, J., Kabashi, E., McDearmid, J., Millecamps, S., Urushitani, M., Lin, L., Dion, P., Zhu, Q., Drapeau, P., J-P Julien, and Rouleau, G. A., Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish., Hum Mol Genet, vol. 17, no. 17, pp. 2691-702, 2008.
S. Millecamps and J-P Julien, [Dysfunction of axonal transport in neuropathies and motor neuron diseases]., Med Sci (Paris), vol. 24, no. 1, pp. 65-71, 2008.
M. Urushitani, Ezzi, S. Abou, Matsuo, A., Tooyama, I., and J-P Julien, The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS., FASEB J, vol. 22, no. 7, pp. 2476-87, 2008.
F. Dequen, Bomont, P., Gowing, G., Cleveland, D. W., and J-P Julien, Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1., J Neurochem, vol. 107, no. 1, pp. 253-64, 2008.
B. Barrette, Hébert, M. - A., Filali, M., Lafortune, K., Vallières, N., Gowing, G., J-P Julien, and Lacroix, S., Requirement of myeloid cells for axon regeneration., J Neurosci, vol. 28, no. 38, pp. 9363-76, 2008.
K. S. Eriksson, Zhang, S., Lin, L., Larivière, R. C., J-P Julien, and Mignot, E., The type III neurofilament peripherin is expressed in the tuberomammillary neurons of the mouse., BMC Neurosci, vol. 9, p. 26, 2008.
J-P Julien, ALS: astrocytes move in as deadly neighbors., Nat Neurosci, vol. 10, no. 5, pp. 535-7, 2007.
J-P Julien and Kriz, J., Chapter 6 Animal models of motor neuron death., Handb Clin Neurol, vol. 82, pp. 121-38, 2007.
S. Millecamps, Gowing, G., Corti, O., Mallet, J., and J-P Julien, Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments., J Neurosci, vol. 27, no. 18, pp. 4947-56, 2007.
J. Zhai, Lin, H., J-P Julien, and Schlaepfer, W. W., Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1., Hum Mol Genet, vol. 16, no. 24, pp. 3103-16, 2007.
H. Galarneau, Villeneuve, J., Gowing, G., J-P Julien, and Vallières, L., Increased glioma growth in mice depleted of macrophages., Cancer Res, vol. 67, no. 18, pp. 8874-81, 2007.
M. Barclay, Noakes, P. G., Ryan, A. F., J-P Julien, and Housley, G. D., Neuronal expression of peripherin, a type III intermediate filament protein, in the mouse hindbrain., Histochem Cell Biol, vol. 128, no. 6, pp. 541-50, 2007.
D. M. Barry, Millecamps, S., J-P Julien, and Garcia, M. L., New movements in neurofilament transport, turnover and disease., Exp Cell Res, vol. 313, no. 10, pp. 2110-20, 2007.
M. Urushitani, Ezzi, S. Abou, and J-P Julien, Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis., Proc Natl Acad Sci U S A, vol. 104, no. 7, pp. 2495-500, 2007.
C. Haenggeli, J-P Julien, R Mosley, L., Perez, N., Dhar, A., Gendelman, H. E., and Rothstein, J. D., Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS., Neurobiol Dis, vol. 26, no. 1, pp. 146-52, 2007.
S. Abou Ezzi, Urushitani, M., and J-P Julien, Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation., J Neurochem, vol. 102, no. 1, pp. 170-8, 2007.

Funding / Support / Partners

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord